HEALTH● LOW1h ago · Sep 3, 2026, 2:52 PM
Pfizer, Medicus ink licensing deal worth up to $1B for antibody drug conjugate
Seeking Alpha Tech · global
Pfizer and Medicus have signed a licensing agreement valued up to $1 billion for an antibody drug conjugate.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH39m ago20 million children a year face online sexual abuse, UNICEF saysAl Jazeera [en]HEALTH56m agoJust 4 of 28 lifts at Queen Mary Hospital block set for service once repairs doneSouth China Morning PostHEALTH2h agoPsychology says that sleepwalkers not only experience these nocturnal wanderings due to sleep disorders, but it can be a warning sign linked to family historyClarínHEALTH2h agoFarmer tests positive for COVID-19 in KuppamThe Hindu